Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

This past year was the third warmest on record and stood on the cusp of surpassing a major climate threshold globally, ...

The Make America Healthy Again (MAHA) movement’s crusade against pesticides is creating divisions in the Republican Party, as ...

While most EU countries continue to face a rise in flu cases, a higher share of citizens are getting vaccinated.

Being exposed to common chemicals used on crops, forests and golf courses may double your risk of developing Parkinson's ...

The foundation is seeking clarity on the type of waste feedstock the proposed facility would process, including whether it ...

WITH coughs and colds already widespread this winter, doctors have warned they are “more severe and slower to clear” in ...

Under the Biden administration, tighter PM2.5 limits were projected to prevent up to 4,500 premature deaths and 290,000 lost ...

The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

NORTHAMPTON, MA / ACCESS Newswire / January 13, 2026 / Starting out 2026, regulatory momentum around Environmental, Health, and Safety (EHS) is accelerating across several regions. For global companie ...

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is starting the new year with its first approved drug. The company received notice from the U.S. Food and Drug ...